Skip to main content
. 2014 May 27;5(11):3895–3906. doi: 10.18632/oncotarget.2019

Figure 1. Images from representative samples with high or low HTATIP2 expression and microvessel density (MVD, indicated by CD34) as determined by immunostaining of tissue microarrays.

Figure 1

(A and C) Case 76 in cohort 1 and (E and G) case 25 in cohort 2 showed high HTATIP2 but low MVD; by contrast, (B and D) case 218 in cohort 1 and (F and H) case 49 in cohort 2 showed low HTATIP2 but high MVD (×200).